A negative Smad2/miR-9/ANO1 regulatory loop is responsible for LPS-induced sepsis

Biomed Pharmacother. 2019 Aug:116:109016. doi: 10.1016/j.biopha.2019.109016. Epub 2019 Jun 4.

Abstract

The roles of miR-9 in tumor progression are well-defined, however, its roles and the mechanisms in sepsis are still unclear. This work aims to explore miR-9 roles and related mechanism in LPS-induced sepsis. We found that miR-9 level was significantly upregulated in septic patients and RAW264.7 cells with LPS treatment, knockdown of miR-9 attenuated the induced effects of LPS on IL-6 and TNF-α secretion. In vivo experiments showed that miR-9 expression was increased in septic mice and knockdown of miR-9 partially reversed the upregulation of IL-6 and TNF-α levels in septic mice and prolonged the survival of septic mice. Mechanistic studies revealed that miR-9 could target ANO1, which inactivates the TGF-β/Smad2 signaling. Conversely, Smad2 could bind to the promoter of miR-9 and promote miR-9 expression. Notably, ANO1 overexpression or Smad2 knockdown attenuated miR-9 knockdown-mediated inhibition on LPS-induced sepsis. Therefore, these results suggest that the negative Smad2/miR-9/ANO1 regulatory loop is responsible for LPS-induced sepsis.

Keywords: ANO1; LPS; RAW264.7; Sepsis; Smad2; miR-9.

MeSH terms

  • Animals
  • Anoctamin-1 / genetics
  • Anoctamin-1 / metabolism*
  • Base Sequence
  • Female
  • Gene Knockdown Techniques
  • Humans
  • Lipopolysaccharides
  • Male
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Middle Aged
  • Promoter Regions, Genetic / genetics
  • Protein Binding
  • RAW 264.7 Cells
  • Sepsis / genetics
  • Sepsis / metabolism*
  • Signal Transduction
  • Smad2 Protein / metabolism*
  • Transforming Growth Factor beta / metabolism
  • Up-Regulation / genetics

Substances

  • Anoctamin-1
  • Lipopolysaccharides
  • MIRN9 microRNA, mouse
  • MIRN92 microRNA, human
  • MicroRNAs
  • Smad2 Protein
  • Transforming Growth Factor beta